Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Humanised Mouse and Rat Model Market: By Type: Humanised Mouse Models, Humanised Rat Models; By Application: Oncology, Immunology and Infectious Diseases, Others; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Humanised Mouse and Rat Model Market Outlook

The global humanised mouse and rat model market reached a value of more than USD 105.9 million in 2021. The industry is further expected to grow at a CAGR of about 10.15% in the forecast period of 2022-2027 to reach a value of over USD 189.10 million by 2027.

 

Global Humanised Mouse and Rat Model Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America and the Asia pacific to Significantly Aid the Humanised Mouse and Rat Model Industry

North America represents one of the leading regions in the global market for humanised mouse and rat model. This can be attributed to growing biomedical research, preclinical activities by CROs and pharmaceutical research and development, continued and responsible use of animals ensured by animal care organisations, increasing monoclonal antibody production in the United States. This, along with the growing stem cell research, and government support and initiatives for the development of protein drugs in Canada, is contributing to the market growth. Additionally, the growing number of investments by the government for the development of innovations in mouse models is spurring market growth. In addition to this, the rising focus by leading market players on market development strategies is positively influencing the growth of the regional market.

Meanwhile, the Asia Pacific region, too, occupies a considerable share in the market due to international alliances for research and development activities in China, initiatives to reduce drug approval time, mandatory animal testing for all pharmaceutical drugs and cosmetics in China, increasing government and private sector investments in life sciences sector, growing consumer demand, and growing biomedical and medical research. In addition to this, research in regenerative medicine in Japan, and the overall flourishing healthcare system of Japan is propelling the growth in the Asia Pacific region. Furthermore, the growth of the biomedical industry in India, development of bio-clusters to boost India’s biotechnology, growth in translational and biomedical research in different countries of the Asia Pacific region is expanding the growth of the market. These trends are likely to continue in the forecast period as well and contribute to the market growth.

 

Humanised Mouse and Rat Model: Market Segmentation

In biology and medical research, a humanised mouse and rat model is a model that comprises functional human genes, cells, tissues, and organs. These mouse and rat models are utilised to simulate a human immune system in both healthy and diseased situations.

 

Global Humanised Mouse and Rat Model Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By type, the market is divided into:

  • Humanised Mouse Models
    • Cell-based Humanised Mouse Model
      • CD34
      • PBMC
      • BLT
    • Genetic Humanised Mouse Model
  • Humanised Rat Models

The market based on application, can be classified into:

  • Oncology
  • Immunology and Infectious Diseases
  • Neuroscience
  • Haematopoiesis
  • Toxicology
  • Others

Based on end use, the market can be categorised into:

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organisations
  • Academic and Research Institutions

The EMR report looks into the regional markets for humanised mouse and rat model like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Humanised Mouse and Rat Model Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Demand for Personalised Medicine Boosting the Market Growth

Due to the growing demand for personalised medication, the market for humanised mouse and rat model is likely to grow at a significant pace during the forecast period, as these medicines are designed using animal models, particularly mice models. In order to determine the most appropriate therapy, the model is treated with a variety of medications or gene therapies, resulting in personalised medication for patients, thereby propelling the market growth. The growth of the market can further be determined by the increasing number of research activities involving humanised models, in pharmaceutical and biotechnology companies, technological developments, use of mouse and rat models for the detection of immunodeficiency disorders, tumours, and other unusual diseases.

Furthermore, the market is expected to be aided by rising applications of the model in cancer research activities, and increasing innovation to develop humanised mouse models tailored to meet the specific needs of cancer research. The growth of humanised mouse model industry can also be attributed to the rising incidences of chronic disorders and growing demand for efficient therapeutic drugs, which is anticipated to bring new opportunities. As a result, the rapidly flourishing medical industry around the world is boosting the market growth of humanised mouse and rat model.

 

Key Industry Players in the  Global Humanised Mouse and Rat Model Market

The report gives a detailed analysis of the following key players in the global humanised mouse and rat model market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • The Jackson Laboratory
  • GenOway S.A.
  • TransGenic Inc.
  • Horizon Discovery Group plc
  • Vitalstar Biotechnology Co., Ltd.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical
and Forecast Market Analysis by Segment- Type, Application, End Use, Region
Breakup by Type Humanised Mouse Models, Humanised Rat Models
Breakup by Application Oncology, Immunology and Infectious Diseases, Neuroscience, Haematopoiesis, Toxicology, Others
Breakup by End Use Pharmaceutical and Biotechnology Companies, Contract Research Organisations, Academic and Research Institutions
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered The Jackson Laboratory, GenOway S.A., TransGenic Inc., Horizon Discovery Group plc, Vitalstar Biotechnology Co., Ltd., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Humanised Mouse and Rat Model Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Humanised Mouse and Rat Model Historical Market (2017-2021) 
    8.3    Global Humanised Mouse and Rat Model Market Forecast (2022-2027)
    8.4    Global Humanised Mouse and Rat Model Market by Type
        8.4.1    Humanised Mouse Models
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
                8.4.1.3.1    Cell-based Humanised Mouse Model
                    8.4.1.3.1.1    CD34
                    8.4.1.3.1.2    PBMC
                    8.4.1.3.1.3    BLT
                8.4.1.3.2    Genetic Humanised Mouse Model
        8.4.2    Humanised Rat Models
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
    8.5    Global Humanised Mouse and Rat Model Market by Application
        8.5.1    Oncology
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Immunology and Infectious Diseases
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Neuroscience
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Haematopoiesis
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Toxicology
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
        8.5.6    Others
    8.6    Global Humanised Mouse and Rat Model Market by End Use
        8.6.1    Pharmaceutical and Biotechnology Companies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Contract Research Organisations
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Academic and Research Institutions
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
    8.7    Global Humanised Mouse and Rat Model Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    The Jackson Laboratory
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    GenOway S.A.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    TransGenic Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Horizon Discovery Group plc
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Vitalstar Biotechnology Co., Ltd.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Humanised Mouse and Rat Model Market: Key Industry Highlights, 2017 and 2027
2.    Global Humanised Mouse and Rat Model Historical Market: Breakup by Type (USD Million), 2017-2021
3.    Global Humanised Mouse and Rat Model Market Forecast: Breakup by Type (USD Million), 2022-2027
4.    Global Humanised Mouse and Rat Model Historical Market: Breakup by Application (USD Million), 2017-2021
5.    Global Humanised Mouse and Rat Model Market Forecast: Breakup by Application (USD Million), 2022-2027
6.    Global Humanised Mouse and Rat Model Historical Market: Breakup by End Use (USD Million), 2017-2021
7.    Global Humanised Mouse and Rat Model Market Forecast: Breakup by End Use (USD Million), 2022-2027
8.    Global Humanised Mouse and Rat Model Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Humanised Mouse and Rat Model Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Humanised Mouse and Rat Model Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Humanised Mouse and Rat Model Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Global Humanised Mouse and Rat Model Market Structure

Key Questions Answered in the Report

In 2021, the global humanised mouse and rat model market attained a value of more than USD 105.9 million.

The market is projected to grow at a CAGR of 10.15% between 2022 and 2027.

The market is estimated to witness a healthy growth rate in the forecast period of 2022-2027 to reach over USD 189.10 million by 2027.

The market is being driven by advancements in personalised medications, heavy investments in the medical research and development, and the growing initiatives to reduce drug approval time.

The market growth can be determined by the use of humanised mouse and rat models for the detection of immunodeficiency disorders, tumours, and other unusual diseases.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major types of humanised mouse and rat models are humanised mouse models and humanised rat models.

The leading applications of humansied mouse and rat models are oncology, immunology and infectious diseases, neuroscience, haematopoiesis, and toxicology, among others.

The significant end uses of humanised mouse and rat models are pharmaceutical and biotechnology companies, contract research organisations, and academic and research institutions.

The major players in the industry are The Jackson Laboratory, GenOway S.A., TransGenic Inc., Horizon Discovery Group plc, and Vitalstar Biotechnology Co., Ltd., among others.

Analyst Review

The global humanised mouse and rat model market attained a value of more than USD 105.9 million in 2021, driven by the growing demand for personalised medicine. Aided by the increasing number of research activities involving humanised models, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 10.15%. The market is projected to reach over USD 189.10 million by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the market is divided into humanised mouse models and humanised rat models. The leading applications of humansied mouse and rat models are oncology, immunology and infectious diseases, neuroscience, haematopoiesis, and toxicology, among others. On the basis of end use, the market can be classified into pharmaceutical and biotechnology companies, contract research organisations, and academic and research institutions. The major regional markets for humanised mouse and rat model are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include The Jackson Laboratory, GenOway S.A., TransGenic Inc., Horizon Discovery Group plc, and Vitalstar Biotechnology Co., Ltd., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER